GDTC
GDTC
NASDAQ · Biotechnology

Cytomed Therapeutics Ltd

$1.17
+0.09 (+8.33%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.99M 1.82M 1.81M
Net Income -271,887 -219,394 -295,477
EPS
Profit Margin -13.7% -12.0% -16.3%
Rev Growth +6.4% +1.5% -4.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.19M 1.92M 2.35M
Total Equity 8.12M 8.19M 8.32M
D/E Ratio 0.27 0.23 0.28
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -443,981 -374,843 -381,153
Free Cash Flow -242,138 -341,295 -221,285